NFKB1 and colorectal cancer: found that inhibition of the HMGB1/RAGE/Snail/NF-κB signaling pathway can reverse HMGB1-induced EMT in colorectal cancer cell line CRC, thereby preventing the migration and invasion of CRC cells (114).